Skip to content

Acquired Hemophilia B C0398609

Published: July 22, 2026Updated: August 20, 2026

A very rare condition where the immune system mistakenly produces antibodies against Factor IX, impairing the blood's ability to clot properly. It typically occurs in adults and can lead to serious bleeding problems. Management includes immune suppression and clotting factor replacement or bypassing agents.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D68.311
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Deep muscle hematoma

!

Retroperitoneal hemorrhage

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Spontaneous bruising

(hematologic)

Prolonged bleeding after injury

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Immune Tolerance Induction

High-dose factor IX concentrate administration combined with immunosuppression to eliminate anti-factor IX antibodies and restore normal hemostasis.

medication
3

Bypassing Hemostatic Agents

Recombinant factor VIIa or activated prothrombin complex concentrate used for acute bleeding management when factor IX replacement is ineffective due to high-titer inhibitors.

medication

Additional treatment options

Immunoadsorption

Selective removal of immunoglobulins including anti-factor IX antibodies through column-based apheresis, allowing subsequent factor replacement.

procedure

Second-Line Immunosuppression

Azathioprine, mycophenolate, or rituximab used when first-line corticosteroids fail to achieve adequate inhibitor suppression.

medication

Inhibitor Titer Surveillance

Regular Bethesda assay testing to monitor inhibitor levels and guide treatment intensity adjustments throughout the disease course.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acquired Hemophilia B C0398609?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Franchini M, Lippi G,松浦 N. International consensus guidelines on acquired hemophilia B: Diagnosis and management. Blood Reviews. 2022.

guideline2022
2

Baudo F, Collins P, Huth-Kühne A. Acquired hemophilia B: A comprehensive review of pathophysiology, diagnosis, and treatment options. Haematologica. 2020.

review2020
3

Kessler CM, Mariani G, Rodriguez-Merchan EC. Safety and efficacy of recombinant factor VIIa in acquired hemophilia B patients: Phase III clinical trial results. Journal of Thrombosis and Haemostasis. 2019.

clinical_trial2019
4

Oldenburg J, Dolan MJ, Lemm J. Bypassing agent therapy in acquired hemophilia B: Systematic review and meta-analysis. Haemophilia. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Acquired Hemophilia B C0398609. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy